AMS HP eNews Bulletin December 2016



  Australasian Menopause Society  
Health Professionals eNewsDecember 2016
  Welcome to AMS HP eNews for doctors and other healthcare professionals who have a special interest in women's health. The content covers information and resources relevant to menopause, midlife and the promotion of healthy ageing.


Season's Greetings from AMS

The AMS would like to take the opportunity to thank its members and friends for their support throughout the year.


The AMS office will close for Christmas at 5pm AEST Friday 23 December and re-open on Tuesday 3 January.


The AMS Board wishes you peace, joy and all the best for the festive season.


May this season of giving and spending time with family bring you happiness that lasts throughout the New Year.


Bronwyn Stuckey
AMS President


20th AMS Congress 

The 20th Australasian Menopause Society Congress was held in Fremantle, Western Australia from 18-20 November 2016.


There were 240 delegates from around Australia, New Zealand as well as France and the USA.


Delegates who attended the Congress were sent a link to view videos of the presentations.


New resources for managing menopausal symptoms after breast cancer treatment  

Cancer Australia has developed new resources for women who experience menopausal symptoms as a result of their treatment for breast cancer, and their health professionals.


Management of menopausal symptoms after treatment for breast cancer can be complex, and needs a different approach to that used by women who enter menopause naturally. However, most symptoms of menopause can be managed with appropriate care.


A new clinical practice guideline, Management of menopausal symptoms in women with a history of breast cancer, provides evidence-based recommendations on the management of menopausal symptoms for all women, regardless of age, who have been treated for breast cancer.


The guideline is endorsed by the Australasian Menopause Society, Breast Cancer Network Australia, Medical Oncology Group of Australia, and BreastSurgANZ.


Management of menopausal symptoms in women with a history of breast cancer

Managing menopausal symptoms after breast cancerThe guideline is accompanied by a consumer guide, Managing menopausal symptoms after breast cancer – A guide for women, which provides information about menopause and managing its symptoms.


Managing menopausal symptoms after breast cancer - a guide for women


Visit for more information.



Join AMS for Member's only content

See exclusive commentary on studies such as:   


Endocrine-disrupting chemicals – are they of concern and can we really reduce our exposure?

There is increasing interest in chemicals called 'endocrine-disrupting chemicals'. These are chemicals, which may be natural or synthetic, that through exposure interfere with an organism's normal hormone balance. The actions of these chemicals are complex. Some have weak endocrine-like actions and others interfere with the pathways through which our hormones normally work, hence the term 'disrupters'. Endocrine disrupter chemicals include chemicals such as DDT and other pesticides, and plasticizers, such as bisphenol A (BPA) as well as phthalates and parabens. The Endocrine Society guideline on this issue in 2009 [1] stated that 'The evidence for adverse reproductive outcomes (infertility, cancers, malformations) from exposure to endocrine-disrupting chemicals is strong, and there is mounting evidence for effects on other endocrine systems, including thyroid, neuroendocrine, obesity and metabolism, and insulin and glucose homeostasis.' The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals, 2015 [2] recognizes this to be an international problem and that more public awareness as to how to minimize personal exposure, plus more research in this area, is needed. Of considerable concern is that endocrine disrupters can cause epigenetic changes, such as DNA methylation which can be transmitted to offspring [2]...


NAMS Menopause Care Updates December 2016  

NAMS presents the December issue of Menopause Care Updates, featuring summaries and in-depth commentaries on recent scientific articles chosen to inform and influence current clinical menopause practice.


Our Menopause World December 2016

Sharing news from the world of menopause and comentary such as:

Rietjens IM, Louisse J, Beekmann K. The potential health effects of dietary phytoestrogens. Br J Pharmacol 2016 Oct 9. Epub ahead of print


The aim of the present review is to present a state-of-the-art overview of the potential health effects of dietary phytoestrogens. Various beneficial health effects have been ascribed to phytoestrogens, such as a lowered risk on menopausal symptoms like hot flushes and osteoporosis, lowered risks on cardiovascular disease, obesity, metabolic syndrome and type 2 diabetes, brain function disorders, breast cancer, prostate cancer, bowel cancer and other cancers. In contrast to these beneficial health claims, the (anti)estrogenic properties of phytoestrogens have also raised concerns since they might act as endocrine disruptors, indicating a potential to cause adverse health effects. The literature overview presented in this paper illustrates that several potential health benefits of phytoestrogens have been reported but that, given the data on potential adverse health effects, the current evidence on these beneficial health effects is not so obvious that they clearly outweigh the possible health risks...

  Australasian Menopause Society
PO Box 511, Inverloch VIC 3996
Tel: +61 3 9428 8738

  Join the Australasian Menopause Society  
Forward this email to a friend